The Asia Pacific Transdermal Patches Market would witness market growth of 6.0% CAGR during the forecast period (2023-2030). In the year 2021, the Asia Pacific market's volume surged to 8,74,026.2 thousand units, showcasing a growth of 5.5% (2019-2022).
The market is marked by dynamic trends that reflect the evolving needs of the healthcare industry and the preferences of both patients and healthcare providers. There is a growing emphasis on designing transdermal patches with a patient-centric approach. This involves considerations such as patch size, ease of application, and minimizing skin irritation, ensuring that patients find the patches convenient and comfortable. The application of these is expanding into new therapeutic areas.
Integrating digital technologies, such as smart patches with embedded sensors, is gaining traction. These patches can monitor patient adherence, vital signs, and other relevant data, providing valuable insights for patients and healthcare professionals. The development of biosimilar transdermal patches is gaining attention. This involves creating patches that are bioequivalent to existing branded patches, offering cost-effective alternatives, and increasing accessibility to patients. The use of these in paediatric populations is on the rise.
The Asia Pacific region is witnessing a rise in the incidence of chronic diseases, including hypertension, diabetes, and cardiovascular conditions, as the population ages. These provide an effective and convenient means of delivering medications for chronic diseases, aligning with the healthcare needs of an aging demographic. As per the data from the World Health Organization, it is projected that by 2040, 28% of the Chinese population will be aged 60 or older due to increasing life expectancy and decreasing fertility rates. Thus, the rising aging population in this region will help expand the market.
The China market dominated the Asia Pacific Transdermal Patches Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $655.9 million by 2030. The Japan market is registering a CAGR of 5.3% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 6.6% during (2023 - 2030).
Based on End User, the market is segmented into Homecare Settings and Hospitals & Clinics. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Based on Adhesive Type, the market is segmented into Acrylic Adhesives, Silicone Adhesives, Hydrogel Adhesives and Others. Based on Patch Type, the market is segmented into Drug-In-Adhesive, Matrix Patches, Reservoir Membrane Patches, Microneedle Patches, Iontophoresis Patches and Vapour Patches. Based on Application, the market is segmented into Pain Management, Smoking Cessation, Hormone Replacement Therapy, Cardiovascular Disorder, Central Nervous System Disorder and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, Viatris, Inc. (Mylan N.V.), Boehringer Ingelheim International GmbH, Endo International PLC, Bayer AG, Nitto Denko Corporation, Cipla Limited, Amneal Pharmaceuticals, Inc., Novartis AG, and AbbVie, Inc.
The market is marked by dynamic trends that reflect the evolving needs of the healthcare industry and the preferences of both patients and healthcare providers. There is a growing emphasis on designing transdermal patches with a patient-centric approach. This involves considerations such as patch size, ease of application, and minimizing skin irritation, ensuring that patients find the patches convenient and comfortable. The application of these is expanding into new therapeutic areas.
Integrating digital technologies, such as smart patches with embedded sensors, is gaining traction. These patches can monitor patient adherence, vital signs, and other relevant data, providing valuable insights for patients and healthcare professionals. The development of biosimilar transdermal patches is gaining attention. This involves creating patches that are bioequivalent to existing branded patches, offering cost-effective alternatives, and increasing accessibility to patients. The use of these in paediatric populations is on the rise.
The Asia Pacific region is witnessing a rise in the incidence of chronic diseases, including hypertension, diabetes, and cardiovascular conditions, as the population ages. These provide an effective and convenient means of delivering medications for chronic diseases, aligning with the healthcare needs of an aging demographic. As per the data from the World Health Organization, it is projected that by 2040, 28% of the Chinese population will be aged 60 or older due to increasing life expectancy and decreasing fertility rates. Thus, the rising aging population in this region will help expand the market.
The China market dominated the Asia Pacific Transdermal Patches Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $655.9 million by 2030. The Japan market is registering a CAGR of 5.3% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 6.6% during (2023 - 2030).
Based on End User, the market is segmented into Homecare Settings and Hospitals & Clinics. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Based on Adhesive Type, the market is segmented into Acrylic Adhesives, Silicone Adhesives, Hydrogel Adhesives and Others. Based on Patch Type, the market is segmented into Drug-In-Adhesive, Matrix Patches, Reservoir Membrane Patches, Microneedle Patches, Iontophoresis Patches and Vapour Patches. Based on Application, the market is segmented into Pain Management, Smoking Cessation, Hormone Replacement Therapy, Cardiovascular Disorder, Central Nervous System Disorder and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, Viatris, Inc. (Mylan N.V.), Boehringer Ingelheim International GmbH, Endo International PLC, Bayer AG, Nitto Denko Corporation, Cipla Limited, Amneal Pharmaceuticals, Inc., Novartis AG, and AbbVie, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End User (Volume, Thousand Units, USD Billion, 2019-2030)- Homecare Settings
- Hospitals & Clinics
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Acrylic Adhesives
- Silicone Adhesives
- Hydrogel Adhesives
- Others
- Drug-In-Adhesive
- Matrix Patches
- Reservoir Membrane Patches
- Microneedle Patches
- Iontophoresis Patches
- Vapour Patches
- Pain Management
- Smoking Cessation
- Hormone Replacement Therapy
- Cardiovascular Disorder
- Central Nervous System Disorder
- Others
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
Companies Profiled- Johnson & Johnson
- Viatris, Inc. (Mylan N.V.)
- Boehringer Ingelheim International GmbH
- Endo International PLC
- Bayer AG
- Nitto Denko Corporation
- Cipla Limited
- Amneal Pharmaceuticals, Inc.
- Novartis AG
- AbbVie, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. Asia Pacific Transdermal Patches Market by End User
Chapter 6. Asia Pacific Transdermal Patches Market by Distribution Channel
Chapter 7. Asia Pacific Transdermal Patches Market by Adhesive Type
Chapter 8. Asia Pacific Transdermal Patches Market by Patch Type
Chapter 9. Asia Pacific Transdermal Patches Market by Application
Chapter 10. Asia Pacific Transdermal Patches Market by Country
Chapter 11. Company Profiles
Companies Mentioned
- Johnson & Johnson
- Viatris, Inc. (Mylan N.V.)
- Boehringer Ingelheim International GmbH
- Endo International PLC
- Bayer AG
- Nitto Denko Corporation
- Cipla Limited
- Amneal Pharmaceuticals, Inc.
- Novartis AG
- AbbVie, Inc.
Methodology
LOADING...
